nodes	percent_of_prediction	percent_of_DWPC	metapath
Perflutren—Rash—Topotecan—peripheral nervous system neoplasm	0.000856	0.000856	CcSEcCtD
Perflutren—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000855	0.000855	CcSEcCtD
Perflutren—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000853	0.000853	CcSEcCtD
Perflutren—Cough—Etoposide—peripheral nervous system neoplasm	0.000852	0.000852	CcSEcCtD
Perflutren—Headache—Topotecan—peripheral nervous system neoplasm	0.00085	0.00085	CcSEcCtD
Perflutren—Rash—Tretinoin—peripheral nervous system neoplasm	0.000849	0.000849	CcSEcCtD
Perflutren—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000849	0.000849	CcSEcCtD
Perflutren—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000849	0.000849	CcSEcCtD
Perflutren—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000849	0.000849	CcSEcCtD
Perflutren—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000848	0.000848	CcSEcCtD
Perflutren—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000848	0.000848	CcSEcCtD
Perflutren—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000848	0.000848	CcSEcCtD
Perflutren—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000846	0.000846	CcSEcCtD
Perflutren—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000845	0.000845	CcSEcCtD
Perflutren—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000845	0.000845	CcSEcCtD
Perflutren—Headache—Tretinoin—peripheral nervous system neoplasm	0.000844	0.000844	CcSEcCtD
Perflutren—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000844	0.000844	CcSEcCtD
Perflutren—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000843	0.000843	CcSEcCtD
Perflutren—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000841	0.000841	CcSEcCtD
Perflutren—Pain—Vincristine—peripheral nervous system neoplasm	0.000841	0.000841	CcSEcCtD
Perflutren—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000841	0.000841	CcSEcCtD
Perflutren—Rash—Melphalan—peripheral nervous system neoplasm	0.000838	0.000838	CcSEcCtD
Perflutren—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000837	0.000837	CcSEcCtD
Perflutren—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000835	0.000835	CcSEcCtD
Perflutren—Dry skin—Epirubicin—peripheral nervous system neoplasm	0.000833	0.000833	CcSEcCtD
Perflutren—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000831	0.000831	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000825	0.000825	CcSEcCtD
Perflutren—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000821	0.000821	CcSEcCtD
Perflutren—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000813	0.000813	CcSEcCtD
Perflutren—Face oedema—Doxorubicin—peripheral nervous system neoplasm	0.000812	0.000812	CcSEcCtD
Perflutren—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000811	0.000811	CcSEcCtD
Perflutren—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000811	0.000811	CcSEcCtD
Perflutren—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000807	0.000807	CcSEcCtD
Perflutren—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000807	0.000807	CcSEcCtD
Perflutren—Nausea—Topotecan—peripheral nervous system neoplasm	0.000806	0.000806	CcSEcCtD
Perflutren—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000804	0.000804	CcSEcCtD
Perflutren—Nausea—Tretinoin—peripheral nervous system neoplasm	0.0008	0.0008	CcSEcCtD
Perflutren—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.0008	0.0008	CcSEcCtD
Perflutren—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000799	0.000799	CcSEcCtD
Perflutren—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000797	0.000797	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000792	0.000792	CcSEcCtD
Perflutren—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00079	0.00079	CcSEcCtD
Perflutren—Nausea—Melphalan—peripheral nervous system neoplasm	0.00079	0.00079	CcSEcCtD
Perflutren—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000781	0.000781	CcSEcCtD
Perflutren—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000777	0.000777	CcSEcCtD
Perflutren—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000777	0.000777	CcSEcCtD
Perflutren—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000777	0.000777	CcSEcCtD
Perflutren—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000777	0.000777	CcSEcCtD
Perflutren—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000775	0.000775	CcSEcCtD
Perflutren—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000774	0.000774	CcSEcCtD
Perflutren—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.000771	0.000771	CcSEcCtD
Perflutren—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.00077	0.00077	CcSEcCtD
Perflutren—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000753	0.000753	CcSEcCtD
Perflutren—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000752	0.000752	CcSEcCtD
Perflutren—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000751	0.000751	CcSEcCtD
Perflutren—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000744	0.000744	CcSEcCtD
Perflutren—Pain—Cisplatin—peripheral nervous system neoplasm	0.000744	0.000744	CcSEcCtD
Perflutren—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000732	0.000732	CcSEcCtD
Perflutren—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000725	0.000725	CcSEcCtD
Perflutren—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000722	0.000722	CcSEcCtD
Perflutren—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000719	0.000719	CcSEcCtD
Perflutren—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000717	0.000717	CcSEcCtD
Perflutren—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000715	0.000715	CcSEcCtD
Perflutren—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.00071	0.00071	CcSEcCtD
Perflutren—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000706	0.000706	CcSEcCtD
Perflutren—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.0007	0.0007	CcSEcCtD
Perflutren—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000698	0.000698	CcSEcCtD
Perflutren—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000694	0.000694	CcSEcCtD
Perflutren—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000688	0.000688	CcSEcCtD
Perflutren—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000687	0.000687	CcSEcCtD
Perflutren—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000687	0.000687	CcSEcCtD
Perflutren—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000686	0.000686	CcSEcCtD
Perflutren—Pain—Etoposide—peripheral nervous system neoplasm	0.000681	0.000681	CcSEcCtD
Perflutren—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000681	0.000681	CcSEcCtD
Perflutren—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000675	0.000675	CcSEcCtD
Perflutren—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000673	0.000673	CcSEcCtD
Perflutren—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000656	0.000656	CcSEcCtD
Perflutren—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000654	0.000654	CcSEcCtD
Perflutren—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000651	0.000651	CcSEcCtD
Perflutren—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00065	0.00065	CcSEcCtD
Perflutren—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000649	0.000649	CcSEcCtD
Perflutren—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000643	0.000643	CcSEcCtD
Perflutren—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000643	0.000643	CcSEcCtD
Perflutren—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000641	0.000641	CcSEcCtD
Perflutren—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.00064	0.00064	CcSEcCtD
Perflutren—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000639	0.000639	CcSEcCtD
Perflutren—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000635	0.000635	CcSEcCtD
Perflutren—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000633	0.000633	CcSEcCtD
Perflutren—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000632	0.000632	CcSEcCtD
Perflutren—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.00063	0.00063	CcSEcCtD
Perflutren—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00063	0.00063	CcSEcCtD
Perflutren—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00063	0.00063	CcSEcCtD
Perflutren—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.00063	0.00063	CcSEcCtD
Perflutren—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000629	0.000629	CcSEcCtD
Perflutren—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000625	0.000625	CcSEcCtD
Perflutren—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000625	0.000625	CcSEcCtD
Perflutren—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000624	0.000624	CcSEcCtD
Perflutren—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000624	0.000624	CcSEcCtD
Perflutren—Rash—Vincristine—peripheral nervous system neoplasm	0.00062	0.00062	CcSEcCtD
Perflutren—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000619	0.000619	CcSEcCtD
Perflutren—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000618	0.000618	CcSEcCtD
Perflutren—Headache—Vincristine—peripheral nervous system neoplasm	0.000616	0.000616	CcSEcCtD
Perflutren—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000606	0.000606	CcSEcCtD
Perflutren—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000606	0.000606	CcSEcCtD
Perflutren—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000595	0.000595	CcSEcCtD
Perflutren—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000592	0.000592	CcSEcCtD
Perflutren—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000587	0.000587	CcSEcCtD
Perflutren—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000587	0.000587	CcSEcCtD
Perflutren—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000586	0.000586	CcSEcCtD
Perflutren—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000585	0.000585	CcSEcCtD
Perflutren—Nausea—Vincristine—peripheral nervous system neoplasm	0.000584	0.000584	CcSEcCtD
Perflutren—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000583	0.000583	CcSEcCtD
Perflutren—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000583	0.000583	CcSEcCtD
Perflutren—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000583	0.000583	CcSEcCtD
Perflutren—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000582	0.000582	CcSEcCtD
Perflutren—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000579	0.000579	CcSEcCtD
Perflutren—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000577	0.000577	CcSEcCtD
Perflutren—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000572	0.000572	CcSEcCtD
Perflutren—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000571	0.000571	CcSEcCtD
Perflutren—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.00057	0.00057	CcSEcCtD
Perflutren—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000568	0.000568	CcSEcCtD
Perflutren—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000566	0.000566	CcSEcCtD
Perflutren—Chills—Epirubicin—peripheral nervous system neoplasm	0.000564	0.000564	CcSEcCtD
Perflutren—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000564	0.000564	CcSEcCtD
Perflutren—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000561	0.000561	CcSEcCtD
Perflutren—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.00056	0.00056	CcSEcCtD
Perflutren—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000553	0.000553	CcSEcCtD
Perflutren—Rash—Cisplatin—peripheral nervous system neoplasm	0.000548	0.000548	CcSEcCtD
Perflutren—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000548	0.000548	CcSEcCtD
Perflutren—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000547	0.000547	CcSEcCtD
Perflutren—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000545	0.000545	CcSEcCtD
Perflutren—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000543	0.000543	CcSEcCtD
Perflutren—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000542	0.000542	CcSEcCtD
Perflutren—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.00054	0.00054	CcSEcCtD
Perflutren—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.00054	0.00054	CcSEcCtD
Perflutren—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000536	0.000536	CcSEcCtD
Perflutren—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000529	0.000529	CcSEcCtD
Perflutren—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000528	0.000528	CcSEcCtD
Perflutren—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000527	0.000527	CcSEcCtD
Perflutren—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000526	0.000526	CcSEcCtD
Perflutren—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000525	0.000525	CcSEcCtD
Perflutren—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000524	0.000524	CcSEcCtD
Perflutren—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000522	0.000522	CcSEcCtD
Perflutren—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.00052	0.00052	CcSEcCtD
Perflutren—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000517	0.000517	CcSEcCtD
Perflutren—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000516	0.000516	CcSEcCtD
Perflutren—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000508	0.000508	CcSEcCtD
Perflutren—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000507	0.000507	CcSEcCtD
Perflutren—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000506	0.000506	CcSEcCtD
Perflutren—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000503	0.000503	CcSEcCtD
Perflutren—Rash—Etoposide—peripheral nervous system neoplasm	0.000502	0.000502	CcSEcCtD
Perflutren—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000502	0.000502	CcSEcCtD
Perflutren—Headache—Etoposide—peripheral nervous system neoplasm	0.000499	0.000499	CcSEcCtD
Perflutren—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000496	0.000496	CcSEcCtD
Perflutren—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000493	0.000493	CcSEcCtD
Perflutren—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000492	0.000492	CcSEcCtD
Perflutren—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000491	0.000491	CcSEcCtD
Perflutren—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.00049	0.00049	CcSEcCtD
Perflutren—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.00049	0.00049	CcSEcCtD
Perflutren—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000487	0.000487	CcSEcCtD
Perflutren—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000484	0.000484	CcSEcCtD
Perflutren—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000481	0.000481	CcSEcCtD
Perflutren—Cough—Epirubicin—peripheral nervous system neoplasm	0.000477	0.000477	CcSEcCtD
Perflutren—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000477	0.000477	CcSEcCtD
Perflutren—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000474	0.000474	CcSEcCtD
Perflutren—Nausea—Etoposide—peripheral nervous system neoplasm	0.000473	0.000473	CcSEcCtD
Perflutren—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000472	0.000472	CcSEcCtD
Perflutren—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.00047	0.00047	CcSEcCtD
Perflutren—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000466	0.000466	CcSEcCtD
Perflutren—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000466	0.000466	CcSEcCtD
Perflutren—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000466	0.000466	CcSEcCtD
Perflutren—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000465	0.000465	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000463	0.000463	CcSEcCtD
Perflutren—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.00046	0.00046	CcSEcCtD
Perflutren—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000457	0.000457	CcSEcCtD
Perflutren—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000456	0.000456	CcSEcCtD
Perflutren—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000455	0.000455	CcSEcCtD
Perflutren—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000454	0.000454	CcSEcCtD
Perflutren—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000453	0.000453	CcSEcCtD
Perflutren—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000447	0.000447	CcSEcCtD
Perflutren—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000447	0.000447	CcSEcCtD
Perflutren—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000447	0.000447	CcSEcCtD
Perflutren—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000445	0.000445	CcSEcCtD
Perflutren—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000442	0.000442	CcSEcCtD
Perflutren—Shock—Epirubicin—peripheral nervous system neoplasm	0.000439	0.000439	CcSEcCtD
Perflutren—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000439	0.000439	CcSEcCtD
Perflutren—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000438	0.000438	CcSEcCtD
Perflutren—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000437	0.000437	CcSEcCtD
Perflutren—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000436	0.000436	CcSEcCtD
Perflutren—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000434	0.000434	CcSEcCtD
Perflutren—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000432	0.000432	CcSEcCtD
Perflutren—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000431	0.000431	CcSEcCtD
Perflutren—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000431	0.000431	CcSEcCtD
Perflutren—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000431	0.000431	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000428	0.000428	CcSEcCtD
Perflutren—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000426	0.000426	CcSEcCtD
Perflutren—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000422	0.000422	CcSEcCtD
Perflutren—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000417	0.000417	CcSEcCtD
Perflutren—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000413	0.000413	CcSEcCtD
Perflutren—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000413	0.000413	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000407	0.000407	CcSEcCtD
Perflutren—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000407	0.000407	CcSEcCtD
Perflutren—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000405	0.000405	CcSEcCtD
Perflutren—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000403	0.000403	CcSEcCtD
Perflutren—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000401	0.000401	CcSEcCtD
Perflutren—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000401	0.000401	CcSEcCtD
Perflutren—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000399	0.000399	CcSEcCtD
Perflutren—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000398	0.000398	CcSEcCtD
Perflutren—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000393	0.000393	CcSEcCtD
Perflutren—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000386	0.000386	CcSEcCtD
Perflutren—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000386	0.000386	CcSEcCtD
Perflutren—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000385	0.000385	CcSEcCtD
Perflutren—Pain—Epirubicin—peripheral nervous system neoplasm	0.000382	0.000382	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000376	0.000376	CcSEcCtD
Perflutren—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000371	0.000371	CcSEcCtD
Perflutren—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000368	0.000368	CcSEcCtD
Perflutren—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000368	0.000368	CcSEcCtD
Perflutren—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000365	0.000365	CcSEcCtD
Perflutren—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000364	0.000364	CcSEcCtD
Perflutren—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000357	0.000357	CcSEcCtD
Perflutren—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000356	0.000356	CcSEcCtD
Perflutren—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000355	0.000355	CcSEcCtD
Perflutren—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000353	0.000353	CcSEcCtD
Perflutren—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000353	0.000353	CcSEcCtD
Perflutren—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000353	0.000353	CcSEcCtD
Perflutren—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00034	0.00034	CcSEcCtD
Perflutren—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000338	0.000338	CcSEcCtD
Perflutren—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000329	0.000329	CcSEcCtD
Perflutren—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000328	0.000328	CcSEcCtD
Perflutren—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000327	0.000327	CcSEcCtD
Perflutren—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000327	0.000327	CcSEcCtD
Perflutren—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.00032	0.00032	CcSEcCtD
Perflutren—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000316	0.000316	CcSEcCtD
Perflutren—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000306	0.000306	CcSEcCtD
Perflutren—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000304	0.000304	CcSEcCtD
Perflutren—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000296	0.000296	CcSEcCtD
Perflutren—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000295	0.000295	CcSEcCtD
Perflutren—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000292	0.000292	CcSEcCtD
Perflutren—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000284	0.000284	CcSEcCtD
Perflutren—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000283	0.000283	CcSEcCtD
Perflutren—Rash—Epirubicin—peripheral nervous system neoplasm	0.000282	0.000282	CcSEcCtD
Perflutren—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000281	0.000281	CcSEcCtD
Perflutren—Headache—Epirubicin—peripheral nervous system neoplasm	0.00028	0.00028	CcSEcCtD
Perflutren—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000273	0.000273	CcSEcCtD
Perflutren—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000265	0.000265	CcSEcCtD
Perflutren—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000263	0.000263	CcSEcCtD
Perflutren—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000261	0.000261	CcSEcCtD
Perflutren—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.00026	0.00026	CcSEcCtD
Perflutren—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000259	0.000259	CcSEcCtD
Perflutren—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000245	0.000245	CcSEcCtD
